US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sagimet Biosciences Inc.

3.59

-0.2400-6.27%

Post-market: 3.590.00000.00%19:31 EDT

Volume:433.97K

Turnover:1.55M

Market Cap:115.58M

PE:-2.47

High:3.79

Open:3.79

Low:3.50

Close:3.83

Loading ...

Overview Company News Filings

With 43% stake, Sagimet Biosciences Inc. (NASDAQ:SGMT) seems to have captured institutional investors' interest

Simply Wall St.

Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Sagimet Biosciences, Inc. Class A (SGMT)

Promising Potential of Denifanstat Drives Buy Rating for Sagimet Biosciences

BRIEF-Sagimet Biosciences Announces Oral Presentation At The 9th Annual MASH-TAG 2025 Conference

Sagimet Biosciences Announces Oral Presentation at the 9TH Annual Mash-Tag 2025 Conference

THOMSON REUTERS

Sagimet Biosciences Announces Oral Presentation at the 9th Annual MASH-TAG 2025 Conference

Sagimet Biosciences (NASDAQ:SGMT) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Chromadex (CDXC) and Sagimet Biosciences, Inc. Class A (SGMT)

BUZZ-Sagimet rises as Oppenheimer initiates coverage with 'outperform'

Oppenheimer Initiates Sagimet Biosciences at Outperform With $30 Price Target

MT Newswires Live

Sagimet Biosciences Initiated at Outperform by Oppenheimer

Sagimet Biosciences Inc : Oppenheimer Initiates Coverage With Outperform Rating; Price Target $30

THOMSON REUTERS

Sagimet Biosciences initiated with an Outperform at Oppenheimer

Sagimet Biosciences to Participate in the Piper Sandler 36th Annual Healthcare Conference

Sagimet Biosciences participates ik,on No

Sagimet Biosciences Presents Clinical Denifanstat and Preclinical FASN Inhibitor Data at AASLD - The Liver Meeting® 2024

Sagimet Biosciences Price Target Maintained With a $32.00/Share by HC Wainwright & Co.

Promising Outlook for Sagimet Biosciences: Buy Rating Driven by Denifanstat’s Clinical Success and Phase 3 MASH Program Initiation

Sagimet Biosciences Advances MASH Treatment with Denifanstat

Sagimet Biosciences, Inc.: Strategic Advancements and Financial Robustness Drive Buy Rating

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SGMT/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SGMT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGMT\",,,,,undefined,":{"symbol":"SGMT","market":"US","secType":"STK","nameCN":"Sagimet Biosciences Inc.","latestPrice":3.59,"timestamp":1746475200000,"preClose":3.83,"halted":0,"volume":433966,"hourTrading":{"tag":"盘后","latestPrice":3.59,"preClose":3.59,"latestTime":"19:31 EDT","volume":324,"amount":1155.47,"timestamp":1746487865438},"delay":0,"floatShares":20491361,"shares":32195345,"eps":-1.453459,"marketStatus":"Not Yet Opened","change":-0.24,"latestTime":"05-05 16:00:00 EDT","open":3.79,"high":3.79,"low":3.5,"amount":1551654.11232,"amplitude":0.075718,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.453459,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746518400000},"marketStatusCode":0,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":3.83,"preHourTrading":{"tag":"盘前","latestPrice":3.7456,"preClose":3.83,"latestTime":"09:14 EDT","volume":200,"amount":749.12,"timestamp":1746450882183},"postHourTrading":{"tag":"盘后","latestPrice":3.59,"preClose":3.59,"latestTime":"19:31 EDT","volume":324,"amount":1155.47,"timestamp":1746487865438},"volumeRatio":0.715135,"impliedVol":2.0676,"impliedVolPercentile":0.617},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGMT\",,,,,undefined,":{"symbol":"SGMT","floatShares":20491361,"roa":"-26.49%","roe":"-36.92%","lyrEps":-1.453459,"volumeRatio":0.715135,"shares":32195345,"dividePrice":0,"high":3.79,"amplitude":0.075718,"preClose":3.83,"low":3.5,"week52Low":1.73,"pbRate":"0.74","week52High":7.38,"institutionHeld":0,"latestPrice":3.59,"eps":-1.453459,"divideRate":0,"volume":433966,"delay":0,"ttmEps":-1.453459,"open":3.79,"prevYearClose":4.5,"prevWeekClose":3.83,"prevMonthClose":3.45,"prevQuarterClose":3.26,"fiveDayClose":3.31,"twentyDayClose":2.08,"sixtyDayClose":4.71},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SGMT\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2504828514","title":"With 43% stake, Sagimet Biosciences Inc. (NASDAQ:SGMT) seems to have captured institutional investors' interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2504828514","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504828514?lang=en_us&edition=fundamental","pubTime":"2025-01-20 18:09","pubTimestamp":1737367778,"startTime":"0","endTime":"0","summary":"Key Insights Institutions' substantial holdings in Sagimet Biosciences implies that they have significant influence...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sgmt/sagimet-biosciences/news/with-43-stake-sagimet-biosciences-inc-nasdaqsgmt-seems-to-ha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2095319765.USD","NDAQ","BK4585","USAW.SI","LU2210150020.SGD","IE00BGHQF748.EUR","QLD","SQQQ","IE00B3QW5Z07.USD","NVIW.SI",".IXIC","BK4139","IE00B64PRP62.GBP","MNQmain","TQQQ","BK4112","LU2210149790.SGD","USJW.SI","TSYW.SI","QID","BK4588","SGMT","IE00BKPKM429.USD","PSQ","NQmain"],"gpt_icon":1},{"id":"2503324894","title":"Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Sagimet Biosciences, Inc. Class A (SGMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2503324894","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503324894?lang=en_us&edition=fundamental","pubTime":"2025-01-13 15:51","pubTimestamp":1736754695,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Eli Lilly & Co (LLY – Research Report) and Sagimet B...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-eli-lilly-co-lly-sagimet-biosciences-inc-class-a-sgmt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-eli-lilly-co-lly-sagimet-biosciences-inc-class-a-sgmt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGMT","SG9999015952.SGD","IE0002141913.USD","LU1712237335.SGD","LU0354030511.USD","SG9999018857.SGD","LU0058720904.USD","LU1551013425.SGD","LU2468319806.SGD","LU1623119135.USD","IE00BFTCPJ56.SGD","BK4139","LU1366192091.USD","SG9999015945.SGD","LU0122379950.USD","GB00BDT5M118.USD","LU0096364046.USD","LU0708995401.HKD","LU2106854487.HKD","LU0238689110.USD","LU1988902786.USD","LU0114720955.EUR","LU0820561818.USD","LU0823416689.USD","SG9999014914.USD","SGXZ51526630.SGD","LU0882574139.USD","SGXZ81514606.USD","LU0097036916.USD","LU2237443978.SGD","LU1868837136.USD","SGXZ31699556.SGD","LU1551013342.USD","LU1917777945.USD","LU1868836914.USD","LU1868836757.USD","LU2491050154.USD","BK4007","LU0094547139.USD","SGXZ99366536.SGD","BK4599","SG9999014906.USD","LLY","LU2265009873.SGD","HCSG","LU2324357040.USD","BK4516","LU1280957306.USD","IE00B1BXHZ80.USD","LU0417517546.SGD"],"gpt_icon":0},{"id":"2503130153","title":"Promising Potential of Denifanstat Drives Buy Rating for Sagimet Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2503130153","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503130153?lang=en_us&edition=fundamental","pubTime":"2025-01-13 08:05","pubTimestamp":1736726756,"startTime":"0","endTime":"0","summary":"Jonathan Wolleben, an analyst from JMP Securities, reiterated the Buy rating on Sagimet Biosciences, Inc. Class A (SGMT – Research Report). The ass...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/promising-potential-of-denifanstat-drives-buy-rating-for-sagimet-biosciences?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/promising-potential-of-denifanstat-drives-buy-rating-for-sagimet-biosciences?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGMT"],"gpt_icon":0},{"id":"2501397682","title":"BRIEF-Sagimet Biosciences Announces Oral Presentation At The 9th Annual MASH-TAG 2025 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2501397682","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501397682?lang=en_us&edition=fundamental","pubTime":"2025-01-06 21:13","pubTimestamp":1736169197,"startTime":"0","endTime":"0","summary":"BRIEF-Sagimet Biosciences Announces Oral Presentation At The 9th Annual MASH-TAG 2025 ConferenceJan 6  - Sagimet Biosciences Inc SGMT.O:SAGIMET BIOSCIENCES ANNOUNCES ORAL PRESENTATION AT THE 9TH ANNUAL MASH-TAG 2025 CONFERENCESource text: nGNXbV84LfFurther company coverage: SGMT.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA2PYTPM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2501239340","title":"Sagimet Biosciences Announces Oral Presentation at the 9TH Annual Mash-Tag 2025 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2501239340","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501239340?lang=en_us&edition=fundamental","pubTime":"2025-01-06 21:00","pubTimestamp":1736168404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA2PYTPM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2501392032","title":"Sagimet Biosciences Announces Oral Presentation at the 9th Annual MASH-TAG 2025 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2501392032","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501392032?lang=en_us&edition=fundamental","pubTime":"2025-01-06 21:00","pubTimestamp":1736168400,"startTime":"0","endTime":"0","summary":"SAN MATEO, Calif., Jan.  06, 2025  (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctiona","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/06/3004574/0/en/Sagimet-Biosciences-Announces-Oral-Presentation-at-the-9th-Annual-MASH-TAG-2025-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT"],"gpt_icon":0},{"id":"2491232501","title":"Sagimet Biosciences (NASDAQ:SGMT) Is In A Good Position To Deliver On Growth Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2491232501","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491232501?lang=en_us&edition=fundamental","pubTime":"2024-12-15 22:16","pubTimestamp":1734272203,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sgmt/sagimet-biosciences/news/sagimet-biosciences-nasdaqsgmt-is-in-a-good-position-to-deli","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2095319765.USD","NDAQ","BK4585","USAW.SI","LU2210150020.SGD","IE00BGHQF748.EUR","QLD","SQQQ","IE00B3QW5Z07.USD","NVIW.SI",".IXIC","BK4139","IE00B64PRP62.GBP","MNQmain","TQQQ","BK4112","LU2210149790.SGD","USJW.SI","TSYW.SI","QID","BK4588","SGMT","IE00BKPKM429.USD","PSQ","NQmain"],"gpt_icon":1},{"id":"2489781269","title":"Analysts Offer Insights on Healthcare Companies: Chromadex (CDXC) and Sagimet Biosciences, Inc. Class A (SGMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2489781269","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489781269?lang=en_us&edition=fundamental","pubTime":"2024-12-08 16:40","pubTimestamp":1733647206,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Chromadex (CDXC – Research Report) and Sagimet Biosc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-chromadex-cdxc-and-sagimet-biosciences-inc-class-a-sgmt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-chromadex-cdxc-and-sagimet-biosciences-inc-class-a-sgmt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4139","HCSG","CDXC","BK4137","SGMT"],"gpt_icon":0},{"id":"2489237474","title":"BUZZ-Sagimet rises as Oppenheimer initiates coverage with 'outperform'","url":"https://stock-news.laohu8.com/highlight/detail?id=2489237474","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489237474?lang=en_us&edition=fundamental","pubTime":"2024-12-07 00:02","pubTimestamp":1733500955,"startTime":"0","endTime":"0","summary":"BUZZ-Sagimet rises as Oppenheimer initiates coverage with 'outperform'** Drug developer Sagimet Biosciences' SGMT.O shares rise 8.4% to $5.05** Oppenheimer starts coverage with \"outperform\" rating and PT at $30 — a 543.8% premium to Thursday's close of $4.66** Brokerage sees \"underappreciated opportunity\" in co's lead experimental drug, denifanstat, being developed to treat metabolic dysfunction-associated steatohepatitis ** MASH is a severe liver disease caused by fat buildup, leading to inflammation and damage** The MASH market is dominated by Madrigal Pharmaceuticals' MDGL.O Rezdiffra** \"We see SGMT as ultimately benefiting from MDGL's build-out of the MASH market as diagnosis rates and reimbursement improve,\" brokerage says ** Oppenheimer expects risk-adjusted peak total revenues of ~$1.9 bln for denifanstat in 2040      ** Including session's move, stock down 8.5% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nL3N3N70WZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDGL","SGMT"],"gpt_icon":0},{"id":"2489252350","title":"Oppenheimer Initiates Sagimet Biosciences at Outperform With $30 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2489252350","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489252350?lang=en_us&edition=fundamental","pubTime":"2024-12-06 21:51","pubTimestamp":1733493115,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences (SGMT) has an average rating of buy and mean price target of $29.14, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPY","SGMT"],"gpt_icon":0},{"id":"2489814052","title":"Sagimet Biosciences Initiated at Outperform by Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2489814052","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489814052?lang=en_us&edition=fundamental","pubTime":"2024-12-06 20:27","pubTimestamp":1733488020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SGMT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 06, 2024 07:27 ET (12:27 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPY","SGMT"],"gpt_icon":0},{"id":"2489247601","title":"Sagimet Biosciences Inc : Oppenheimer Initiates Coverage With Outperform Rating; Price Target $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2489247601","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489247601?lang=en_us&edition=fundamental","pubTime":"2024-12-06 14:28","pubTimestamp":1733466501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nFWN3N7028:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2489153644","title":"Sagimet Biosciences initiated with an Outperform at Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2489153644","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489153644?lang=en_us&edition=fundamental","pubTime":"2024-12-06 05:17","pubTimestamp":1733433443,"startTime":"0","endTime":"0","summary":"Oppenheimer initiated coverage of Sagimet Biosciences (SGMT) with an Outperform rating and $30 price target Published first on TheFly – the ultimat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-initiated-with-an-outperform-at-oppenheimer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-initiated-with-an-outperform-at-oppenheimer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","SGMT"],"gpt_icon":0},{"id":"2486183077","title":"Sagimet Biosciences to Participate in the Piper Sandler 36th Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2486183077","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486183077?lang=en_us&edition=fundamental","pubTime":"2024-11-26 21:00","pubTimestamp":1732626000,"startTime":"0","endTime":"0","summary":"SAN MATEO, Calif., Nov.  26, 2024  (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc.(Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/26/2987446/0/en/Sagimet-Biosciences-to-Participate-in-the-Piper-Sandler-36th-Annual-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","SGMT","BK4137","BK4139"],"gpt_icon":0},{"id":"2484903475","title":"Sagimet Biosciences participates ik,on No","url":"https://stock-news.laohu8.com/highlight/detail?id=2484903475","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484903475?lang=en_us&edition=fundamental","pubTime":"2024-11-20 05:00","pubTimestamp":1732050020,"startTime":"0","endTime":"0","summary":"Biotech Analyst Agrawal holds a conference call with CEO Happel and CFO Chauche on November 22 at 12 pm hosted by Cantor Fitzgerald. ():(https://ca...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-participates-ikon-no?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-participates-ikon-no?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2484962214","title":"Sagimet Biosciences Presents Clinical Denifanstat and Preclinical FASN Inhibitor Data at AASLD - The Liver Meeting® 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2484962214","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484962214?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:00","pubTimestamp":1731934800,"startTime":"0","endTime":"0","summary":"Subset analysis of FASCINATE-2 Phase 2 trial demonstrated denifanstat improved fibrosis in difficult-to-treat MASH patients. Both artificial intelligence  and conventional pathology demonstrated denifanstat's strong anti-fibrotic activity. SAN MATEO, Calif., Nov. 18, 2024  -- Sagimet Biosciences Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced the presentation of Phase 2b data demonstrating the anti-fibrotic activity of its fatty acid synthase  inhibitor denifanstat, and preclinical data demonstrating potential benefit of FASN inhibition in atherosclerosis, at the American Association for the Study of Liver Disease  - The Liver Meeting 2024, November 15-19, 2024 in San Diego, California.GLP1 receptor agonist population: 42% denifanstat  vs 0% placebo (n=4) . Type 2 diabetes population: 40% denifanstat  vs 19% placebo  . PNPLA3 I148 carrier population: 30% denifanstat  vs 6% placebo  ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vN9syB.4joRY7zqfsihqcg--~B/aD05NDE7dz0yNTYwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/f62671a6941ad62a5569bf4eb2a2514a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vN9syB.4joRY7zqfsihqcg--~B/aD05NDE7dz0yNTYwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/f62671a6941ad62a5569bf4eb2a2514a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sagimet-biosciences-presents-clinical-denifanstat-130000389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SHG","BK4207","SGMT","BK4139"],"gpt_icon":0},{"id":"2483584337","title":"Sagimet Biosciences Price Target Maintained With a $32.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2483584337","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483584337?lang=en_us&edition=fundamental","pubTime":"2024-11-16 03:46","pubTimestamp":1731699960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SGMT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 15, 2024 14:46 ET (19:46 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT"],"gpt_icon":0},{"id":"2483092013","title":"Promising Outlook for Sagimet Biosciences: Buy Rating Driven by Denifanstat’s Clinical Success and Phase 3 MASH Program Initiation","url":"https://stock-news.laohu8.com/highlight/detail?id=2483092013","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483092013?lang=en_us&edition=fundamental","pubTime":"2024-11-16 00:15","pubTimestamp":1731687310,"startTime":"0","endTime":"0","summary":"Analyst Ed Arce from H.C. Wainwright maintained a Buy rating on Sagimet Biosciences, Inc. Class A (SGMT – Research Report) and keeping the price ta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/promising-outlook-for-sagimet-biosciences-buy-rating-driven-by-denifanstats-clinical-success-and-phase-3-mash-program-initiation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/promising-outlook-for-sagimet-biosciences-buy-rating-driven-by-denifanstats-clinical-success-and-phase-3-mash-program-initiation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGMT"],"gpt_icon":0},{"id":"2483394225","title":"Sagimet Biosciences Advances MASH Treatment with Denifanstat","url":"https://stock-news.laohu8.com/highlight/detail?id=2483394225","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483394225?lang=en_us&edition=fundamental","pubTime":"2024-11-15 12:34","pubTimestamp":1731645291,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences, Inc. Class A ( ($SGMT) ) has released its Q3 earnings. Here is a breakdown of the information Sagimet Biosciences, Inc. Class ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sagimet-biosciences-advances-mash-treatment-with-denifanstat?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sagimet-biosciences-advances-mash-treatment-with-denifanstat?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2483490367","title":"Sagimet Biosciences, Inc.: Strategic Advancements and Financial Robustness Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2483490367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483490367?lang=en_us&edition=fundamental","pubTime":"2024-11-15 10:15","pubTimestamp":1731636908,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences, Inc. Class A (SGMT) has received a new Buy rating, initiated by TD Cowen analyst, Ritu Baral. Ritu Baral has given her Buy rat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sagimet-biosciences-inc-strategic-advancements-and-financial-robustness-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sagimet-biosciences-inc-strategic-advancements-and-financial-robustness-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGMT"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":48,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGMT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGMT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGMT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.6667,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1738036800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SGMT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SGMT","date":"2025-05-02","current":-2.77674,"percent":0.904206,"low":-15.666506,"twenty":-7.146955,"median":-4.575776,"eighty":-3.219588,"high":-1.342444,"avg":-5.398048,"sd":2.829902,"marketCap":126527705},"quantilePoints":[{"date":"2023-07-21","current":-12.287206,"twenty":-13.337015,"median":-12.553129,"eighty":-11.625533,"marketCap":348354576},{"date":"2023-07-28","current":-12.208993,"twenty":-12.714826,"median":-12.49838,"eighty":-12.113574,"marketCap":346137170},{"date":"2023-08-04","current":-12.733018,"twenty":-12.595364,"median":-12.529665,"eighty":-12.271563,"marketCap":360993794},{"date":"2023-08-11","current":-12.514023,"twenty":-12.565643,"median":-12.517933,"eighty":-12.42486,"marketCap":354785056},{"date":"2023-08-18","current":-9.925184,"twenty":-12.565643,"median":-12.514023,"eighty":-12.265307,"marketCap":281388897},{"date":"2023-08-25","current":-9.359416,"twenty":-12.554693,"median":-12.471006,"eighty":-10.020915,"marketCap":262381858},{"date":"2023-09-01","current":-9.85717,"twenty":-12.553129,"median":-12.459274,"eighty":-9.809842,"marketCap":276335907},{"date":"2023-09-08","current":-10.126447,"twenty":-12.543743,"median":-12.279385,"eighty":-9.775571,"marketCap":283884818},{"date":"2023-09-15","current":-9.791891,"twenty":-12.532793,"median":-11.532454,"eighty":-9.775571,"marketCap":274505868},{"date":"2023-09-22","current":-8.282308,"twenty":-12.524972,"median":-10.126447,"eighty":-9.674388,"marketCap":232186213},{"date":"2023-09-29","current":-7.392878,"twenty":-12.517151,"median":-9.936056,"eighty":-9.403479,"marketCap":207251930},{"date":"2023-10-06","current":-5.866975,"twenty":-12.514023,"median":-9.90613,"eighty":-8.80291,"marketCap":164474765},{"date":"2023-10-13","current":-4.757227,"twenty":-12.495252,"median":-9.80821,"eighty":-7.764969,"marketCap":133364100},{"date":"2023-10-20","current":-3.729078,"twenty":-12.478045,"median":-9.791891,"eighty":-6.978354,"marketCap":104540984},{"date":"2023-10-27","current":-3.647479,"twenty":-12.474916,"median":-9.751091,"eighty":-6.462648,"marketCap":102253435},{"date":"2023-11-03","current":-3.100765,"twenty":-12.467095,"median":-9.681732,"eighty":-5.866975,"marketCap":86926858},{"date":"2023-11-10","current":-2.284775,"twenty":-12.467095,"median":-9.514454,"eighty":-4.757227,"marketCap":64051369},{"date":"2023-11-17","current":-1.981702,"twenty":-12.459274,"median":-9.396135,"eighty":-4.030995,"marketCap":53347428},{"date":"2023-11-24","current":-3.487116,"twenty":-12.32162,"median":-9.116089,"eighty":-3.455541,"marketCap":93873157},{"date":"2023-12-01","current":-3.248971,"twenty":-12.280949,"median":-8.665823,"eighty":-3.326797,"marketCap":87462307},{"date":"2023-12-08","current":-3.436085,"twenty":-12.223071,"median":-7.870232,"eighty":-3.326797,"marketCap":92499403},{"date":"2023-12-15","current":-4.74588,"twenty":-11.827315,"median":-7.466317,"eighty":-3.305106,"marketCap":127759077},{"date":"2023-12-22","current":-4.79691,"twenty":-11.412789,"median":-6.927763,"eighty":-3.326797,"marketCap":129132830},{"date":"2023-12-29","current":-5.009539,"twenty":-10.856914,"median":-6.462648,"eighty":-3.351567,"marketCap":134856803},{"date":"2024-01-05","current":-4.286601,"twenty":-10.142767,"median":-6.27497,"eighty":-3.385054,"marketCap":115395295},{"date":"2024-01-12","current":-6.055674,"twenty":-10.126447,"median":-6.038333,"eighty":-3.402064,"marketCap":163018751},{"date":"2024-01-19","current":-5.494334,"twenty":-10.061168,"median":-5.928097,"eighty":-3.422477,"marketCap":147907462},{"date":"2024-01-26","current":-11.924235,"twenty":-11.412789,"median":-6.047003,"eighty":-3.434384,"marketCap":321000405},{"date":"2024-02-02","current":-11.8484,"twenty":-11.755197,"median":-6.332089,"eighty":-3.449693,"marketCap":318958920},{"date":"2024-02-09","current":-7.10904,"twenty":-11.755197,"median":-6.72671,"eighty":-3.480312,"marketCap":191375352},{"date":"2024-02-16","current":-10.260714,"twenty":-11.412789,"median":-7.18072,"eighty":-3.487116,"marketCap":276218424},{"date":"2024-02-23","current":-7.973973,"twenty":-11.272575,"median":-7.393401,"eighty":-3.512632,"marketCap":214659353},{"date":"2024-03-01","current":-7.263069,"twenty":-10.976358,"median":-7.495026,"eighty":-3.600344,"marketCap":195521817},{"date":"2024-03-08","current":-7.642218,"twenty":-10.478725,"median":-7.466317,"eighty":-3.696438,"marketCap":205728503},{"date":"2024-03-15","current":-5.118509,"twenty":-10.189946,"median":-7.39314,"eighty":-3.910228,"marketCap":137790253},{"date":"2024-03-22","current":-5.509506,"twenty":-10.132975,"median":-7.18072,"eighty":-4.056781,"marketCap":148315897},{"date":"2024-03-28","current":-6.56,"twenty":-10.093807,"median":-7.132737,"eighty":-4.084178,"marketCap":182866572},{"date":"2024-04-05","current":-6.239442,"twenty":-10.00568,"median":-6.795721,"eighty":-4.174333,"marketCap":173930684},{"date":"2024-04-12","current":-5.976126,"twenty":-9.938231,"median":-6.56,"eighty":-4.313817,"marketCap":166590490},{"date":"2024-04-19","current":-4.545061,"twenty":-9.925184,"median":-6.397368,"eighty":-4.392065,"marketCap":126698131},{"date":"2024-04-26","current":-4.487819,"twenty":-9.917562,"median":-6.217851,"eighty":-4.458405,"marketCap":125102437},{"date":"2024-05-03","current":-5.09459,"twenty":-9.886546,"median":-6.182199,"eighty":-4.468439,"marketCap":142016797},{"date":"2024-05-10","current":-5.231972,"twenty":-9.844114,"median":-6.079163,"eighty":-4.479356,"marketCap":145846463},{"date":"2024-05-17","current":-5.429865,"twenty":-9.811474,"median":-6.018678,"eighty":-4.487871,"marketCap":151590963},{"date":"2024-05-24","current":-5.372708,"twenty":-9.791891,"median":-5.987575,"eighty":-4.491214,"marketCap":149995268},{"date":"2024-05-31","current":-6.172899,"twenty":-9.791891,"median":-5.987575,"eighty":-4.501006,"marketCap":172334989},{"date":"2024-06-07","current":-5.315552,"twenty":-9.783731,"median":-5.976126,"eighty":-4.523122,"marketCap":148399574},{"date":"2024-06-14","current":-5.47559,"twenty":-9.751091,"median":-5.952111,"eighty":-4.533251,"marketCap":152867518},{"date":"2024-06-21","current":-4.446773,"twenty":-9.731508,"median":-5.91688,"eighty":-4.519544,"marketCap":124145020},{"date":"2024-06-28","current":-4.698262,"twenty":-9.718452,"median":-5.91688,"eighty":-4.523122,"marketCap":131166075},{"date":"2024-07-05","current":-3.257919,"twenty":-9.685812,"median":-5.888477,"eighty":-4.48795,"marketCap":90954577},{"date":"2024-07-12","current":-3.738033,"twenty":-9.677652,"median":-5.800519,"eighty":-4.448199,"marketCap":104358410},{"date":"2024-07-15","current":-3.806621,"twenty":-9.67602,"median":-5.796735,"eighty":-4.447058,"marketCap":106273243},{"date":"2024-08-02","current":-3.97809,"twenty":-9.674388,"median":-5.79295,"eighty":-4.391494,"marketCap":111060326},{"date":"2024-08-09","current":-3.109312,"twenty":-9.635837,"median":-5.632964,"eighty":-4.048186,"marketCap":86805772},{"date":"2024-08-16","current":-3.011259,"twenty":-9.556995,"median":-5.529634,"eighty":-3.765468,"marketCap":88082328},{"date":"2024-08-23","current":-3.174914,"twenty":-9.5049,"median":-5.509506,"eighty":-3.626007,"marketCap":92869411},{"date":"2024-08-30","current":-3.36039,"twenty":-9.480538,"median":-5.47559,"eighty":-3.517501,"marketCap":98294771},{"date":"2024-09-06","current":-2.913065,"twenty":-9.458966,"median":-5.429865,"eighty":-3.459899,"marketCap":85210078},{"date":"2024-09-13","current":-3.709522,"twenty":-9.418167,"median":-5.410329,"eighty":-3.440029,"marketCap":108507215},{"date":"2024-09-20","current":-3.578597,"twenty":-9.3382,"median":-5.372708,"eighty":-3.459899,"marketCap":104677549},{"date":"2024-09-27","current":-3.076721,"twenty":-9.217671,"median":-5.306102,"eighty":-3.426198,"marketCap":89997161},{"date":"2024-10-04","current":-4.495067,"twenty":-9.063099,"median":-5.281258,"eighty":-3.402458,"marketCap":131485214},{"date":"2024-10-11","current":-4.516888,"twenty":-9.008144,"median":-5.226248,"eighty":-3.408396,"marketCap":132123492},{"date":"2024-10-18","current":-5.891593,"twenty":-8.972181,"median":-5.273199,"eighty":-3.426198,"marketCap":172334989},{"date":"2024-10-25","current":-6.000697,"twenty":-8.935294,"median":-5.292689,"eighty":-3.429281,"marketCap":175526378},{"date":"2024-10-31","current":-5.826131,"twenty":-8.894301,"median":-5.311818,"eighty":-3.436085,"marketCap":170420156},{"date":"2024-11-08","current":-6.753511,"twenty":-8.791513,"median":-5.372708,"eighty":-3.436763,"marketCap":197546960},{"date":"2024-11-15","current":-5.651565,"twenty":-8.755967,"median":-5.41811,"eighty":-3.453095,"marketCap":165313934},{"date":"2024-11-22","current":-3.861691,"twenty":-8.665823,"median":-5.372708,"eighty":-3.487116,"marketCap":144879052},{"date":"2024-11-29","current":-4.882893,"twenty":-8.557843,"median":-5.315552,"eighty":-3.487116,"marketCap":183191513},{"date":"2024-12-06","current":-3.998995,"twenty":-8.332016,"median":-5.292689,"eighty":-3.504949,"marketCap":150030307},{"date":"2024-12-13","current":-3.896017,"twenty":-8.272608,"median":-5.273199,"eighty":-3.525595,"marketCap":146166866},{"date":"2024-12-20","current":-4.350838,"twenty":-8.042693,"median":-5.190447,"eighty":-3.550034,"marketCap":163230399},{"date":"2024-12-27","current":-4.35942,"twenty":-7.978712,"median":-5.107971,"eighty":-3.56885,"marketCap":163552352},{"date":"2025-01-03","current":-3.853109,"twenty":-7.96022,"median":-5.094591,"eighty":-3.578236,"marketCap":144557099},{"date":"2025-01-10","current":-4.608284,"twenty":-7.932249,"median":-5.088866,"eighty":-3.585335,"marketCap":172889002},{"date":"2025-01-17","current":-3.664315,"twenty":-7.891035,"median":-5.014451,"eighty":-3.578519,"marketCap":137474123},{"date":"2025-01-24","current":-3.561337,"twenty":-7.843641,"median":-5.001034,"eighty":-3.577995,"marketCap":133610681},{"date":"2025-01-31","current":-3.484103,"twenty":-7.800873,"median":-4.931489,"eighty":-3.565628,"marketCap":130713100},{"date":"2025-02-07","current":-4.041903,"twenty":-7.796247,"median":-4.899965,"eighty":-3.577995,"marketCap":151640074},{"date":"2025-02-14","current":-3.775875,"twenty":-7.711114,"median":-4.882893,"eighty":-3.5785,"marketCap":141659518},{"date":"2025-02-21","current":-3.454068,"twenty":-7.655997,"median":-4.848447,"eighty":-3.56477,"marketCap":129586263},{"date":"2025-02-28","current":-3.097934,"twenty":-7.585345,"median":-4.824006,"eighty":-3.534402,"marketCap":116225195},{"date":"2025-03-07","current":-3.13226,"twenty":-7.533213,"median":-4.786117,"eighty":-3.487116,"marketCap":117513009},{"date":"2025-03-14","current":-2.479989,"twenty":-7.4778,"median":-4.774032,"eighty":-3.471231,"marketCap":113005660},{"date":"2025-03-21","current":-2.861526,"twenty":-7.417463,"median":-4.751553,"eighty":-3.434384,"marketCap":130391147},{"date":"2025-03-28","current":-2.656626,"twenty":-7.395771,"median":-4.728869,"eighty":-3.400275,"marketCap":121054497},{"date":"2025-04-04","current":-1.603868,"twenty":-7.392983,"median":-4.702859,"eighty":-3.36039,"marketCap":73083433},{"date":"2025-04-11","current":-1.575606,"twenty":-7.289031,"median":-4.694849,"eighty":-3.31696,"marketCap":71795619},{"date":"2025-04-17","current":-1.42723,"twenty":-7.21366,"median":-4.648098,"eighty":-3.301626,"marketCap":65034596},{"date":"2025-04-25","current":-2.204435,"twenty":-7.173257,"median":-4.603993,"eighty":-3.254074,"marketCap":100449476},{"date":"2025-05-02","current":-2.77674,"twenty":-7.146955,"median":-4.575776,"eighty":-3.219588,"marketCap":126527705}],"updateTime":1746464722631}}}